The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT-Reference-Cited by-同舟云学术

The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT

Published:2022-04-11 Issue:10 Volume:49 Page:3401-3411
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Monaco Lavinia^ORCID,De Bernardi Elisabetta^ORCID,Bono Francesca,Cortinovis Diego^ORCID,Crivellaro Cinzia^ORCID,Elisei Federica,L’Imperio Vincenzo^ORCID,Landoni Claudio^ORCID,Mathoux Gregory,Musarra Monica,Pagni Fabio^ORCID,Turolla Elia Anna,Messa Cristina,Guerra Luca^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-022-05783-z.pdf

Reference16 articles.

1. Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348:124–8.

2. Hersom M, Jørgensen JT. Companion and complementary diagnostics-focus on PD-L1 expression assays for PD-1/PD-L1 checkpoint inhibitors in non-small cell lung Cancer. Ther Drug Monit. 2018;40:9–16.

3. Ilie M, Long-Mira E, Bence C, Butori C, Lassalle S, Bouhlel L, et al. Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies. Ann Oncol. 2016;27:147–53.

4. McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, et al. Quantitative assessment of the heterogeneity of PD-L1 Expression in non-small-cell lung cancer. JAMA Oncol. 2016;2:46–54.

5. Bubendorf L, Lantuejoul S, de Langen AJ, Thunnissen E. Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens: Number 2 in the Series “Pathology for the clinician” Edited by Peter Dorfmüller and Alberto Cavazza. Eur Respir Rev [Internet]. 2017;26. Available from: https://doi.org/10.1183/16000617.0007-2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in artificial intelligence applications in the field of lung cancer;Frontiers in Oncology;2024-09-06

2. Prediction of HER2 Expression in Gastric Adenocarcinoma Based On Preoperative Noninvasive Multimodal 18F-FDG PET/CT Imaging;Academic Radiology;2024-08

3. Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer;Frontiers in Oncology;2024-07-26

4. Assessment of PD‐L1 Expression in Non‐Small Cell Lung Cancers Using [⁶⁸Ga]Ga‐DOTA‐WL12 PET/CT;Small Methods;2024-06-16

5. Correlation between Radiological Characteristics, PET-CT and Histological Subtypes of Primary Lung Adenocarcinoma—A 102 Case Series Analysis;Medicina;2024-04-10